Citations

Clear

511 citation(s) found for "Seth, N".

Endoscopic diagnosis and treatment of esophageal verrucous squamous cell cancer
Sweetser, Seth , Jacobs, Nisha L. , Song, Louis M. Wong Kee

Mayo Clinic

Diseases of the Esophagus | October 15, 2012 | Volume: 27 | Issue: 5 | Pages: 452-456

10.1111/j.1442-2050.2012.01434.x | PMID 23067443 Get It

Novel technique for placement of overlapping self-expandable metal stents to close a massive pancreatitis-induced duodenal fistula
Rao, Amulya A. Nageswara , Bonin, Eduardo A. , Sweetser, Seth , Baron, T. , Leroy, A

Mayo Clinic

Endoscopy | May 23, 2012 | Volume: 44 | Issue: S 02 | Pages: E163-E164

10.1055/s-0031-1291760 | PMID 22622723 Get It

A randomized, double masked, controlled trial of botulinum toxin type A in essential hand tremor
Brin, Mitchell F. , Lyons, Kelly E. , Caviness, John N., Comella, Cynthia L., Dubinsky, Richard , Friedman, J H, Manyam, B. V., Matsumoto, Joseph Y., Pullman, Seth L. , Rajput, Ali H. , Tanner, Caroline M., Koller, William C., Doucette, John T. , Adler, Charles H. , Sethi, Kapil D.

Mayo Clinic

Neurology | May 13, 2012 | Volume: 56 | Issue: 11 | Pages: 1523-1528

10.1212/wnl.56.11.1523 | PMID 11402109 Get It

Influence of age and sex on the pressor response following a spontaneous burst of muscle sympathetic nerve activity
Vianna, Lauro C. , Hart, Emma C. , Fairfax, Seth T., Charkoudian, Nisha , Joyner, Michael J. , Fadel, Paul J. , Hart, Emma C

Mayo Clinic

American Journal of Physiology-Heart and Circulatory Physiology | March 16, 2012 | Volume: 302 | Issue: 11 | Pages: H2419-H2427

10.1152/ajpheart.01105.2011 | PMID 22427525 Get It

The sympathetic nervous system is critical for the beat-to-beat regulation of arterial blood pressure (BP). Although studies have examined age- and sex-related effects on BP control, findings are inconsistent and limited data are available in postmenopausal women. In addition, the majority of studies have focused on time-averaged responses without consideration for potential beat-to-beat alterations. Thus we examined whether the ability of muscle sympathetic nerve activity (MSNA) to modulate BP on a beat-to-beat basis is affected by age or sex. BP and MSNA were measured during supine rest in 40 young (20 men) and 40 older (20 men) healthy subjects. Beat-to-beat fluctuations in mean arterial pressure (MAP) were characterized for 15 cardiac cycles after each MSNA burst using signal averaging. The rise in MAP following an MSNA burst was similar between young men and women (+2.64 ± 0.3 vs. +2.57 ± 0.3 mmHg, respectively). However, the magnitude of the increase in MAP after an MSNA burst was reduced in older compared with young subjects ( P < 0.05). Moreover, the attenuation of the pressor response was greater in older women (+1.20 ± 0.1 mmHg) compared with older men (+1.72 ± 0.2 mmHg; P < 0.05). Interestingly, in all groups, MAP consistently decreased after cardiac cycles without MSNA bursts (nonbursts) with the magnitude of fall greatest in older men. In summary, healthy aging is associated with an attenuated beat-to-beat increase in BP after a spontaneous MSNA burst, and this attenuation is more pronounced in postmenopausal women. Furthermore, our nonburst findings highlight the importance of sympathetic vasoconstrictor activity to maintain beat-to-beat BP, particularly in older men.
Clinical Practice Guideline
Stachler, Robert J., Chandrasekhar, Sujana S. , Archer, Sanford M., Schwartz, Seth, Barrs, David M., Fife, Terry D., Ford, Peg, Ganiats, Théodore G. , Hollingsworth, Deena B., Lewandowski, Christopher , Montano, Joseph J., Saunders, James E., Tucci, Debara L. , Valente, Michael , Warren, Barbara, Yaremchuk, Kathleen , Rosenfeld, Richard M. , Brown, Steven Ross , Robertson, Peter J.

Mayo Clinic

Otolaryngology–Head and Neck Surgery | March 1, 2012 | Volume: 146 | Issue: S3 | Pages: No page available

10.1177/0194599812436449 | PMID 22383545 Get It

Objective Sudden hearing loss (SHL) is a frightening symptom that often prompts an urgent or emergent visit to a physician. This guideline provides evidence‐based recommendations for the diagnosis, management, and follow‐up of patients who present with SHL. The guideline primarily focuses on sudden sensorineural hearing loss (SSNHL) in adult patients (aged 18 and older). Prompt recognition and management of SSNHL may improve hearing recovery and patient quality of life (QOL). Sudden sensorineural hearing loss affects 5 to 20 per 100,000 population, with about 4000 new cases per year in the United States. This guideline is intended for all clinicians who diagnose or manage adult patients who present with SHL. Purpose The purpose of this guideline is to provide clinicians with evidence‐based recommendations in evaluating patients with SHL, with particular emphasis on managing SSNHL. The panel recognized that patients enter the health care system with SHL as a nonspecific, primary complaint. Therefore, the initial recommendations of the guideline deal with efficiently distinguishing SSNHL from other causes of SHL at the time of presentation. By focusing on opportunities for quality improvement, the guideline should improve diagnostic accuracy, facilitate prompt intervention, decrease variations in management, reduce unnecessary tests and imaging procedures, and improve hearing and rehabilitative outcomes for affected patients. Results The panel made strong recommendations that clinicians should (1) distinguish sensorineural hearing loss from conductive hearing loss in a patient presenting with SHL; (2) educate patients with idiopathic sudden sensorineural hearing loss (ISSNHL) about the natural history of the condition, the benefits and risks of medical interventions, and the limitations of existing evidence regarding efficacy; and (3) counsel patients with incomplete recovery of hearing about the possible benefits of amplification and hearing‐assistive technology and other supportive measures. The panel made recommendations that clinicians should (1) assess patients with presumptive SSNHL for bilateral SHL, recurrent episodes of SHL, or focal neurologic findings; (2) diagnose presumptive ISSNHL if audiometry confirms a 30‐dB hearing loss at 3 consecutive frequencies and an underlying condition cannot be identified by history and physical examination; (3) evaluate patients with ISSNHL for retrocochlear pathology by obtaining magnetic resonance imaging, auditory brainstem response, or audiometric follow‐up; (4) offer intratympanic steroid perfusion when patients have incomplete recovery from ISSNHL after failure of initial management; and (5) obtain follow‐up audiometric evaluation within 6 months of diagnosis for patients with ISSNHL. The panel offered as options that clinicians may offer (1) corticosteroids as initial therapy to patients with ISSNHL and (2) hyperbaric oxygen therapy within 3 months of diagnosis of ISSNHL. The panel made a recommendation against clinicians routinely prescribing antivirals, thrombolytics, vasodilators, vasoactive substances, or antioxidants to patients with ISSNHL. The panel made strong recommendations against clinicians (1) ordering computerized tomography of the head/brain in the initial evaluation of a patient with presumptive SSNHL and (2) obtaining routine laboratory tests in patients with ISSNHL.
A comparison of high definition-image enhanced colonoscopy and standard white-light colonoscopy for colorectal polyp detection
Gross, Seth A. , Buchner, Anna M. , Cangemi, J., Picco, Michael F., Wolfsen, Herbert C. , DeVault, Kenneth R. , Loeb, David M. , Raimondo, Massimo , Woodward, Timothy A., Wallace, Michael B. , Crook, Julia E. , Wallace, Michael B

Mayo Clinic

Endoscopy | October 4, 2011 | Volume: 43 | Issue: 12 | Pages: 1045-1051

10.1055/s-0030-1256894 | PMID 21971929 Get It

Ano1 as a regulator of proliferation
Stanich, Jennifer E., Gibbons, Simon J. , Eisenman, Seth T., Bardsley, Michael R., Rock, Jason R. , Harfe, Brian D. , Ördög, Tamás , Farrugia, Gianrico , Gibbons, S J

Mayo Clinic

American Journal of Physiology-Gastrointestinal and Liver Physiology | September 23, 2011 | Volume: 301 | Issue: 6 | Pages: G1044-G1051

10.1152/ajpgi.00196.2011 | PMID 21940901 Get It

Ano1 is a recently discovered Ca2+-activated Cl− channel expressed on interstitial cells of Cajal (ICC) that has been implicated in slow-wave activity in the gut. However, Ano1 is expressed on all classes of ICC, even those that do not contribute to generation of the slow wave, suggesting that Ano1 may have an alternate function in these cells. Ano1 is also highly expressed in gastrointestinal stromal tumors. Mice lacking Ano1 had fewer proliferating ICC in whole mount preparations and in culture, raising the possibility that Ano1 is involved in proliferation. Cl− channel blockers decreased proliferation in cells expressing Ano1, including primary cultures of ICC and in the pancreatic cancer-derived cell line, CFPAC-1. Cl− channel blockers had a reduced effect on Ano1(−/−) cultures, confirming that the blockers are acting on Ano1. Ki67 immunoreactivity, 5-ethynyl-2′-deoxyuridine incorporation, and cell-cycle analysis of cells grown in low-Cl− media showed fewer proliferating cells than in cultures grown in regular medium. We confirmed that mice lacking Ano1 had less phosphorylated retinoblastoma protein compared with controls. These data led us to conclude that Ano1 regulates proliferation at the G1/S transition of the cell cycle and may play a role in tumorigenesis.
Thirteen-lined ground squirrels ( Ictidomys tridecemlineatus ) show microstructural bone loss during hibernation but preserve bone macrostructural geometry and strength
McGee‐Lawrence, Meghan E. , Stoll, Danielle M., Mantila, Emily R., Fahrner, Bryna K., Carey, Hannah V. , Donahue, Seth W. , McGee-Lawrence, Meghan E

Mayo Clinic

Journal of Experimental Biology | March 23, 2011 | Volume: 214 | Issue: 8 | Pages: 1240-1247

10.1242/jeb053520 | PMID 21430199 Get It

SUMMARY Lack of activity causes bone loss In most animals. Hibernating bears have physiological processes to prevent cortical and trabecular bone loss associated with reduced physical activity, but different mechanisms of torpor among hibernating species may lead to differences in skeletal responses to hibernation. There are conflicting reports regarding whether small mammals experience bone loss during hibernation. To investigate this phenomenon, we measured cortical and trabecular bone properties in physically active and hibernating juvenile and adult 13-lined ground squirrels (Ictidomys tridecemlineatus, previous genus name Spermophilus). Cortical bone geometry, strength and mineral content were similar in hibernating compared with active squirrels, suggesting that hibernation did not cause macrostructural cortical bone loss. Osteocyte lacunar size increased (linear regression, P=0.001) over the course of hibernation in juvenile squirrels, which may indicate an osteocytic role in mineral homeostasis during hibernation. Osteocyte lacunar density and porosity were greater (+44 and +59%, respectively; P&lt;0.0001) in hibernating compared with active squirrels, which may reflect a decrease in osteoblastic activity (per cell) during hibernation. Trabecular bone volume fraction in the proximal tibia was decreased (–20%; P=0.028) in hibernating compared with physically active adult squirrels, but was not different between hibernating and active juvenile squirrels. Taken together, these data suggest that 13-lined ground squirrels may be unable to prevent microstructural losses of cortical and trabecular bone during hibernation, but importantly may possess a biological mechanism to preserve cortical bone macrostructure and strength during hibernation, thus preventing an increased risk of bone fracture during remobilization in the spring.
Long-Term Outcome After ICD and CRT Implantation and Influence of Remote Device Follow-Up
Saxon, Leslie A. , Hayes, David L. , Gilliam, F. Roosevelt, Heidenreich, Paul A. , Seth, Milan, Meyer, Timothy E. , Jones, Paul W. , Boehmer, John , Day, John

Mayo Clinic

Circulation | November 23, 2010 | Volume: 122 | Issue: 23 | Pages: 2359-2367

10.1161/circulationaha.110.960633 | PMID 21098452 Get It

Background— Outcome data for patients receiving implantable cardioverter-defibrillator (ICD) and cardiac resynchronization therapy–defibrillator (CRT-D) devices treated outside of clinical trials are lacking. No clinical trial has evaluated mortality after device implantation or after shock therapy in large numbers of patients with implanted devices that regularly transmit device data over a network. Methods and Results— Survival status in patients implanted with ICD and CRT devices across the United States from a single manufacturer was assessed. Outcomes were compared between patients followed in device clinic settings and those who regularly transmit remote data collected from the device an average of 4 times monthly. Shock delivery and electrogram analysis could be ascertained from patients followed on the network, enabling survival after ICD shock to be evaluated. One- and 5-year survival rates in 185 778 patients after ICD implantation were 92% and 68% and were 88% and 54% for CRT-D device recipients. In 8228 patients implanted with CRT-only devices, survival was 82% and 48% at 1 and 5 years, respectively. For the 69 556 ICD and CRT-D patients receiving remote follow-up on the network, 1- and 5-year survival rates were higher compared with those in the 116 222 patients who received device follow-up in device clinics only (50% reduction; P <0.0001). There were no differences between patients followed on or off the remote network for the characteristics of age, gender, implanted device year or type, and economic or educational status. Shock therapy was associated with subsequent mortality risk for both ICD and CRT-D recipients. Conclusions— Survival after ICD and CRT-D implantation in patients treated in naturalistic practice compares favorably with survival rates observed in clinical trials. Remote follow-up of device data is associated with excellent survival, but arrhythmias that result in device therapy in this population are associated with a higher mortality risk compared with patients who do not require shock therapy.
Impact of Overall Treatment Time on Survival and Local Control in Patients With Anal Cancer: A Pooled Data Analysis of Radiation Therapy Oncology Group Trials 87-04 and 98-11
Ben‐Josef, Edgar , Moughan, Jennifer, Flam, Marshall S., Gunderson, Leonard L., Pollock, Jondavid , Myerson, Robert J., Anne, Rani, Willett, Christopher G. , Ajani, Jaffer A. , Rosenthal, Seth A.

Mayo Clinic

Journal of Clinical Oncology | October 19, 2010 | Volume: 28 | Issue: 34 | Pages: 5061-5066

10.1200/jco.2010.29.1351 | PMID 20956625 Get It

PurposeTo determine whether increased duration of radiation therapy (RT) and overall treatment (RX) time has a detrimental effect in anal cancer.Patients and MethodsData from Radiation Therapy Oncology Group (RTOG) 87-04 and RTOG 98-11 trials were combined to form three treatment groups: RT/fluorouracil (FU)/mitomycin (n = 472), RT/FU/cisplatin (n = 320), and RT/FU (n = 145). Cox proportional hazards models were used with the following variables: RT duration, RT intensity, RX duration, treatment group, age, sex, Karnofsky performance score (KPS), T stage, N stage, and RT dose.ResultsIn the univariate analysis, there was a significant association between RX duration and colostomy failure (CF; hazard ratio [HR] = 1.51; 95% CI, 1.07 to 2.14; P = .02), local failure (HR = 1.52; 95% CI, 1.14 to 2.03; P = .005), locoregional failure (HR = 1.51; 95% CI, 1.15 to 1.98; P = .003), and time to failure (HR = 1.40; 95% CI, 1.10 to 1.79; P = .007). The significance of RX duration was maintained after adjusting for treatment group. In multivariate modeling there was a trend toward an association between RX duration and CF (HR = 1.57; 95% CI, 0.98 to 2.50; P = .06) and a statistically significant association with local failure (HR = 1.96; 95% CI, 1.34 to 2.87; P = .0006). Age, sex, KPS, T stage, N stage, and RT dose, but not RT duration, RT intensity, or RX duration, were found to be statistically significant predictors of OS and colostomy-free survival.ConclusionTotal treatment time, but not duration of radiation therapy, seems to have a detrimental effect on local failure and colostomy rate in anal cancer. Induction chemotherapy may contribute to local failure by increasing total treatment time.